Cyclic AMP, a Mediator of GLP-1, Acts in Concert with Glucose and Tolbutamide to Increase Cytosolic Ca2+ in Pancreatic B-Cells

  • Kazuro Yaekura
  • Masanori Nakata
  • Hiromitsu Tanaka
  • Toshihiko Yada
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 426)


Cyclic AMP (cAMP) plays an important role in the regulation of islet B-cell function and stimulates insulin release in a glucose-dependent manner(1). Several physiologic peptides such as truncated glucagon-like peptide-1 (GLP-1), gastric inhibitory peptide (GIP) and glucagon are known to elevate cAMP level in islets and stimulate insulin release also in a glucose-dependent manner(1–4). It has been recently shown that both a rise in cAMP and these peptides increase the cytosolic free Ca2+ concentration ([Ca2+]i) in pancreatic B-cells(3–7), the key intracellular signal that triggers exocytosis of insulin(8,9). The increase in [Ca2+]i is also glucose-dependent(6) and is tightly linked to insulin release(3). However, the mechanisms for the glucose-dependent action of cAMP to increase [Ca2+]i is not well understood. Whether cAMP increases [Ca2+]i via specific cooperation with glucose, a fuel secretagogue, or also with other types of insulin secretagogues is of particular importance. Whether the glucose-dependent action of the peptides to increase [Ca2+]i is mediated by a rise in cAMP is not thoroughly determined.


Insulin Release Pituitary Adenylate Cyclase Activate Polypeptide Gastric Inhibitory Polypeptide Stimulate Insulin Release Krebs Ringer Bicarbonate Buffer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sharp, G.W.G., 1979, The adenylate cyclase-cyclic AMP system in islets of Langerhans and its role in the control of insulin release, Diabetologia 16:287–296.PubMedCrossRefGoogle Scholar
  2. 2.
    Orskov, C., 1992, Glucagon-like peptide-1, a new hormone of the enteroinsular axis, Diabetologia 35: 701–711.PubMedGoogle Scholar
  3. 3.
    Lu, M., Wheeler, M.B., Leng, X.-H., and Boyd, A.E., 1993, The role of the free cytosolic calcium level in β-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7–37), Endocrinology 132:94–100.PubMedCrossRefGoogle Scholar
  4. 4.
    Wang, J.L., Corbett, J.A., Marshall, C.A., and McDaniel, M.L., 1993, Glucose-induced insulin secretion from purified β-cells. A role for modulation of Ca2+ influx by cAMP-and protein kinase C-dependent signal transduction pathways, J. Biol Chem. 268:7785–7791.PubMedGoogle Scholar
  5. 5.
    Grapengiesser, E., Gylfe, E., and Hellman, B., 1991, Cyclic AMP as a determinant for glucose induction of fast Ca2+ oscillations in isolated pancreatic β-cells, J. Biol. Chem. 266:12207–12210.PubMedGoogle Scholar
  6. 6.
    Yada, T., Itoh, K., and Nakata, M., 1993, Glucagon-like peptide-1(7–36)amide and a rise in cyclic adenosine 3′,5′-monophosphate increase cytosolic free Ca2+ in rat pancreatic β-cells by enhancing Ca2+ channel activity, Endocrinology 133:1685–1692.PubMedCrossRefGoogle Scholar
  7. 7.
    Cullinan, C.A., Brady, E.J., Saperstein, R., and Leibowitz, M.D., 1994, Glucose-dependent alterations of intracellular free calcium by glucagon-like peptide-1(7–36amide) in individual ob/ob mouse β-cells, Cell Calcium 15:391–400.PubMedCrossRefGoogle Scholar
  8. 8.
    Penner, R., and Neher, E., 1988, The role of calcium in stimulus-secretion coupling in excitable and non-excitable cells, J. Exp. Biol. 139:329–345.PubMedGoogle Scholar
  9. 9.
    Ämmälä, C., Eliasson, L., Bokvist, K., Larsson, O., Ashcroft, F.M., and Rorsman, P., 1993, Exocytosis elicited by action potentials and voltage-clamp calcium currents in individual mouse pancreatic B-cells, J. Physiol. 472:665–688.PubMedGoogle Scholar
  10. 10.
    Yada, T., Sakurada, M., Ihida, K., Nakata, M., Murata, F., Arimura, A. and Kikuchi, M., 1994, Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet β-cells, J. Biol. Chem. 269:1290–1293.PubMedGoogle Scholar
  11. 11.
    Grynkiewicz, G., Poenie, M., and Tsien, R.Y., 1985, A new generation of Ca2+ indicators with greatly improved fluorescence properties, J. Biol. Chem. 260:3440–3450.PubMedGoogle Scholar
  12. 12.
    Yada, T., Kakei, M., and Tanaka, H., 1992, Single pancreatic β-cells from normal rats exhibit an initial decrease and subsequent increase in cytosolic free Ca2+ in response to glucose, Cell Calcium 13:69–76.PubMedCrossRefGoogle Scholar
  13. 13.
    Ashcroft, F.M., and Rorsman, P., 1989, Electrophysiology of the pancreatic β-cell, Prog. Biophys. Molec. Biol. 54:87–147.CrossRefGoogle Scholar
  14. 14.
    Holz, G.G., Kuhtreiber, W.M., and Habener, J.F., 1993, Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7–37), Nature 361:362–365.PubMedCrossRefGoogle Scholar
  15. 15.
    Ämmälä, C., Ashcroft, F.M., and Rorsman, P., 1993, Calcium-independent potentiation of insulin release by cyclic AMP in single B-cells, Nature 363:356–358.PubMedCrossRefGoogle Scholar
  16. 16.
    Ämmälä, C., Eliasson, L., Bokvist, K., Berggren, P.-O., Honkanen, R.E., Sjöholm, A., and Rorsman, P., 1994, Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic β cells, Proc. Natl. Acad. Sci. 91:4343–4347.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Kazuro Yaekura
    • 1
    • 2
  • Masanori Nakata
    • 1
  • Hiromitsu Tanaka
    • 2
  • Toshihiko Yada
    • 1
  1. 1.Department of PhysiologyKagoshima University School of MedicineKagoshima 890Japan
  2. 2.First Department of Internal MedicineKagoshima University School of MedicineKagoshima 890Japan

Personalised recommendations